A. Duffton

发表

The potential clinical benefit of respiratory gated radiotherapy (RGRT) in non-small cell lung cancer (NSCLC).

R. Muirhead, K. Moore, C. Featherstone, 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Advanced practice: An ESTRO RTTC position paper

M. Leech, Y. Tsang, A. Duffton, 2019, Technical innovations & patient support in radiation oncology.

Dosimetric impact of organ at risk daily variation during prostate stereotactic ablative radiotherapy.

A. Sadoyze, P. McLoone, A. Duffton, 2020, The British journal of radiology.

The in-silico feasibility of dose escalated, hypofractionated radiotherapy for rectal cancer

P. McLoone, A. Duffton, N. MacLeod, 2022, Clinical and translational radiation oncology.

Meeting the challenges imposed by COVID-19: Guidance document by the ESTRO Radiation TherapisT Committee (RTTC)

M. Rossi, M. Leech, Y. Tsang, 2020, Technical Innovations & Patient Support in Radiation Oncology.

Predicting radiotherapy-induced xerostomia in head and neck cancer patients using day-to-day kinetics of radiomics features

W. Nailon, R. Jena, D. McLaren, 2022, Physics and imaging in radiation oncology.

Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial.

J. Staffurth, V. Hinder, E. Hall, 2022, The Lancet. Oncology.

The Pivotal Role of the Therapeutic Radiographer/Radiation Therapist in Image-guided Radiotherapy Research and Development.

E. Forde, A. Duffton, W. Li, 2020, Clinical oncology (Royal College of Radiologists (Great Britain)).

Assessing the generalisability of radiomics features previously identified as predictive of radiation-induced sticky saliva and xerostomia

W. Nailon, R. Jena, D. McLaren, 2022, Physics and imaging in radiation oncology.

Analysis of dose using CBCT and synthetic CT during head and neck radiotherapy: A single centre feasibility study

S. Schipani, D. Grose, P. McLoone, 2020, Technical innovations & patient support in radiation oncology.

Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial

G. Rodrigues, J. Staffurth, T. Tsakiridis, 2019, The Lancet. Oncology.

Feasibility of DW-MRI analysis of salivary glands during head and neck radiotherapy

P. McLoone, A. Duffton, C. Paterson, 2021, Technical innovations & patient support in radiation oncology.

Sub-regional analysis of the parotid glands: model development for predicting late xerostomia with radiomics features in head and neck cancer patients

W. Nailon, R. Jena, D. McLaren, 2023, Acta oncologica.

Potential for Isotoxic Re-irradiation Stereotactic Ablative Body Radiotherapy in Locally Recurrent Rectal Cancer.

K. Aitken, R. Muirhead, A. Duffton, 2022, Clinical oncology (Royal College of Radiologists (Great Britain)).

Intensity-modulated Radiotherapy for Rectal Cancer in the UK in 2020

R. Muirhead, M. Teo, D. Sebag‐Montefiore, 2021, Clinical oncology (Royal College of Radiologists (Great Britain)).

Study of diffusion weighted MRI as a predictive biomarker of response during radiotherapy for high and intermediate risk squamous cell cancer of the oropharynx: The MeRInO study

S. Allwood-Spiers, D. Grose, A. Chalmers, 2017, Clinical and translational radiation oncology.

Clinical commissioning of online seed matching protocol for prostate radiotherapy.

R. Muirhead, A. Alhasso, A. Duffton, 2012, The British journal of radiology.

Diversity in radiation therapist/therapeutic radiographer (RTT) advanced practice (AP) roles delivering on the four domains

K. Moore, A. Duffton, A. Williamson, 2021, Technical innovations & patient support in radiation oncology.

PRIMUS-002: A multicentre, open-label, phase II study examining FOLFOX and nab-paclitaxel (FA) and nab-paclitaxel and gemcitabine (AG) as neoadjuvant therapy for (borderline) resectable pancreatic cancer (PC), focusing on biomarker and liquid biopsy development.

A. Biankin, D. Chang, N. Jamieson, 2019, Journal of Clinical Oncology.

PACE: Analysis of acute toxicity in PACE-B, an international phase III randomized controlled trial comparing stereotactic body radiotherapy (SBRT) to conventionally fractionated or moderately hypofractionated external beam radiotherapy (CFMHRT) for localized prostate cancer (LPCa).

J. Staffurth, V. Hinder, C. Griffin, 2019, Journal of Clinical Oncology.

An assessment of cone beam CT in the adaptive radiotherapy planning process for non-small-cell lung cancer patients.

S. Harrow, A. Duffton, C. Lamb, 2016, The British journal of radiology.